USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark VITROGRO was filed as Word mark on 08/28/2014 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 04/12/2016.
The current status of the mark is "IR CANCELLED; US REGISTRATION CANCELLED".
| Trademark form | Word mark |
| File reference | 79155336 |
| Register number | 4934476 |
| Application date | August 28, 2014 |
| Publication date | January 26, 2016 |
| Entry date | April 12, 2016 |
Trademark owner
Institute of Health & Biomedical Innovat
Trademark representatives
goods and services
1
chemicals for use in science and industry, namely, biological tissue cultures other than for medical or veterinary purposes; biological products for use in science and industry, namely, a 3-dimensional living skin model comprising a de-cellurized de-epidermized dermis prepared from donor skin, for in vitro and in vivo scientific and research purposes and not for medical use, namely, investigating wound healing, pharmaceutics, toxicology, drug sensitivity, drug penetration and drug delivery, and recombinant therapeutic proteins for medical treatments; biochemicals, in the nature of proteins, for in vitro and in vivo scientific or research use, namely, vitronectin, fibronectin, insulin-like growth factor-I, insulin-like growth factor II, insulin-like growth factor binding proteins, epidermal growth factor, fibroblast growth factors, a combination of one or more of the foregoing proteins, portions of one or more of the foregoing proteins, and chimeric proteins containing any combination of the foregoing proteins or portions thereof; proteins for use in the manufacture of vaccines and bio-pharmaceuticals, namely, vitronectin, fibronectin, insulin-like growth factor-I, insulin-like growth factor II, insulin-like growth factor binding proteins, epidermal growth factor, fibroblast growth factors, a combination of one or more of the foregoing proteins, portions of one or more of the foregoing proteins, and chimeric proteins containing any combination of the foregoing proteins or portions thereof; kits containing biochemicals, namely, cell culture kits containing cell culture media and reagents for scientific and research use; biological products for use in science and industry, namely, biochemicals in the nature of proteins in raw form for cell culture and tissue engineering research, proteins for use in the clinical manufacture of vaccines, bio-pharmaceuticals, preparations for wound treatments, cell cultures and wound dressings; chemical reagents, namely, recombinant proteins for scientific and research use; chemicals for use in science and industry, namely, chemical preparations for cell culture for scientific and research use; chemical reagents, namely, biochemical reagents for scientific and research use and not for medical purposes; chemical reagents for scientific and research use and not for medical or veterinary purposes
5
biological preparations, namely, spray-on skin and cultured skin grafts for burn treatment and reconstructive ophthalmic or bladder surgeries, and recombinant therapeutic proteins for medical treatment of burns, hard to heal wounds, surgically created wounds, and incisions; pharmaceutical preparations for treating burns and venous ulcers, wounds in diabetics, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and cosmetic surgeries; veterinary preparations for horses, cattle, pigs, cats and dogs for treating burns and venous ulcers, wounds in diabetics, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and excisional surgeries; chemical preparations for cell culture for medical purposes, namely, for wound treatment; chemical reagents for medical use; biochemical reagents for medical use; recombinant proteins for medical use, namely, for use in cell culture autologous treatments, and for the treatment of burn and venous ulcer wounds, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after surgery; biological preparations for medical use, namely, vitronectin, fibronectin, insulin-like growth factor-I, insulin-like growth factor II, insulin-like growth factor binding proteins, epidermal growth factor, fibroblast growth factor, a combination of one or more of the foregoing proteins, portions of one or more of the foregoing proteins, and chimeric proteins containing any combination of the foregoing proteins or portions thereof, for the treatment of burn and venous ulcer wounds, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after surgery; biological tissue culture media for use in skin cell culture used for medical purposes; pharmaceutical preparations for skin care used for treating burns, venous ulcers, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and cosmetic surgeries, and for improving the appearance of wrinkles and skin defects; medical dressings, surgical dressings, wound care components, namely, wound and surgical dressings; surgical implants, namely, arterial grafts; drugs, namely, topical creams, gels and sprays for medical purposes for treating burns, venous ulcers, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and cosmetic surgeries; drugs, namely, topical creams, gels and sprays for veterinary purposes for use on horses, cattle, pigs, cats or dogs for treating burns, venous ulcers, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and excisional surgeries; vaccines
ID: 1379155336